Overview
- 13 FDA inspections are on record.
- 1 inspection produced a Form 483.
- The most recent recorded inspection date is 2025-05-05.
At a glance
Inspections
13
Form 483s
1
EIRs
1
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 28 Apr 2025 – 5 May 2025 | Human Drugs | 483 | View 483 → |
| 8 Feb 2019 – 8 Mar 2019 | Human Drugs | Clean | |
| 6 Sep 2017 – 14 Sep 2017 | Foods & Cosmetics | Clean | |
| 11 Jun 2014 – 12 Jun 2014 | Human Drugs | Clean | |
| 2 Aug 2012 | Not recorded | Clean | |
| 13 Jan 2011 | Not recorded | Clean | |
| 23 Feb 2010 | Not recorded | Clean | |
| 3 Jun 2009 | Not recorded | Clean | |
| 26 Feb 2008 | Not recorded | Clean | |
| 22 Nov 2006 | Not recorded | Clean | |
| 3 Dec 2004 | Not recorded | Clean | |
| 13 Aug 2002 | Not recorded | Clean | |
Observations on record
Form 483 observations cited at this site, most recent first.
5 May 2025
21 CFR 211.192
Investigations of discrepancies, failures
Cited by Tamil Arasu, Alisha B Patel
5 May 2025
21 CFR 211.22(a)
Contract drug products--lack of responsibility
Cited by Tamil Arasu, Alisha B Patel
5 May 2025
21 CFR 211.22(d)
Procedures not in writing, fully followed
Cited by Tamil Arasu, Alisha B Patel
Investigators
FDA investigators tied to this site in the record.
James A Liubicich4 insp.
Charisse K Green2 insp.
Tamil Arasu1 insp.
Alisha B Patel1 insp.
Rachael A Moliver1 insp.
Carrie E Jolly1 insp.
Samina S Khan1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.166(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.170(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Geri-Care Pharmaceuticals Corp.'s 1 Form 483
Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat